Secukinumab 300mg/2ml solution for injection pre-filled disposable devices
NHS hospitals in England used £125,268,646 of indicative cost of Secukinumab 300mg/2ml solution for injection pre-filled disposable devices in the 12 months to April 2026, about 0.5% of all hospital medicines spend. That is up 18.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Secukinumab 300mg/2ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Secukinumab 300mg/2ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Luton & Dunstable Hospital Trust | £3,538,118 |
| Western Sussex Hospitals Nhs Found Trust | £3,352,864 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £3,137,140 |
| Aintree University Hospital Nhs Ft | £3,067,669 |
| Co.durham & Darlington Nhs Foundation Tr | £3,039,637 |
| Derby Teaching Hospitals Nhs Found Trust | £2,951,885 |
| Leeds Teaching Hpls Nhs Trust | £2,826,351 |
| Salford Royal Nhs Foundation Trust | £2,791,006 |
| Gloucestershire Hpls Nhs Foundation Trst | £2,749,568 |
| Colchester Hospital University Nhs Ft | £2,424,153 |
The primary-care picture
Secukinumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Secukinumab medicine page.